Pei Ma
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research 27
- MicroRNA in disease regulation 10
- NF-κB Signaling Pathways 5
- Molecular Biology top 2%
- RNA modifications and cancer 23
- Circular RNAs in diseases 12
- RNA Research and Splicing 11
- Cancer-related gene regulation 6
- Kruppel-like factors research 6
- Nephrology top 5%
- Immunology top 10%
- Co-authors
- Yutian PanXi WuYongqian ShuTongpeng XuWei LiYuan FangQiming WangTao Yu
- Journals
- Frontiers in Pharmacology (5 papers)Biomedicine & Pharmacotherapy (4 papers)Molecular Therapy — Nucleic Acids (3 papers)
- Partner nations
- ChinaUnited StatesChile
In The Last Decade
Pei Ma
100 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Cancer Research 2.4k
- Molecular Biology 3.4k
- Pulmonary and Respiratory Medicine 640
- Nephrology 130
- Immunology 384
Countries citing papers authored by Pei Ma
This map shows the geographic impact of Pei Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei Ma more than expected).
Fields of papers citing papers by Pei Ma
This network shows the impact of papers produced by Pei Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei Ma. The network helps show where Pei Ma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pei Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 31 | |
| 7 | 2023 | 28 | |
| 8 | 2022 | 8 | |
| 9 | 2022 | 15 | |
| 10 | 2021 | 23 | |
| 11 | 2021 | 3 | |
| 12 | 2021 | 7 | |
| 13 | 2020 | 15 | |
| 14 | 2019 | 27 | |
| 15 | 2019 | 36 | |
| 16 | 2019 | 6 | |
| 17 | 2018 | 183 | |
| 18 | 2018 | 59 | |
| 19 | 2018 | 20 | |
| 20 | Protective effects of icariin on cisplatin-induced acute renal injury in mice. | 2015 | 52 |
About Pei Ma
Pei Ma is a scholar working on Cancer Research, Molecular Biology and Complementary and alternative medicine, having authored 102 papers that have together received 4.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (27 papers), RNA modifications and cancer (23 papers), Circular RNAs in diseases (12 papers), RNA Research and Splicing (11 papers), MicroRNA in disease regulation (10 papers), Cancer-related gene regulation (6 papers), Kruppel-like factors research (6 papers) and NF-κB Signaling Pathways (5 papers). The work is most often cited by research in Cancer Research (2.4k citations), Molecular Biology (3.4k citations) and Pulmonary and Respiratory Medicine (640 citations). Pei Ma has collaborated with scholars based in China, United States and Chile. Frequent co-authors include Yutian Pan, Xi Wu, Yongqian Shu, Yongqian Shu, Tongpeng Xu, Wei Li, Yuan Fang, Qiming Wang, Tao Yu and Yu Tang. Their work appears in journals such as Frontiers in Pharmacology, Biomedicine & Pharmacotherapy, Molecular Therapy — Nucleic Acids, EBioMedicine and Journal of Hematology & Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.